M

Magenta Therapeutics

45 employees

Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Hematopoietic Stem Cell Biology
Autoimmune Diseases
Therapeutics
Medical
Transplant Medicine
Blood Disorders

Date founded

2016

Funding rounds raised

Total raised

$86M

from 15 investors over 15 rounds

M

Magenta Therapeutics raised $86M on May 12, 2021

Investors: TCG X and Great Point Partners

M

Magenta Therapeutics raised $52M on April 9, 2018

Investors: Access Industries, Be The Match BioTherapies, Eventide Asset Management and Casdin Capital, LLC

M

Magenta Therapeutics raised $50M on May 2, 2017

Investors: Access Industries, Be The Match BioTherapies, GV, Third Rock Ventures, Partners HealthCare, Casdin Capital, LLC and Atlas Venture

M

Magenta Therapeutics raised $49M on November 16, 2016

Investors: Atlas Venture and Third Rock Ventures

FAQ